Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment.
Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment.
复制标题
DOI:
10.1093/jncics/pkac073
复制
发表时间:
2022-11-01
影响因子:
4.4
通讯作者:
中科院分区:
文献类型:
--
作者:
The US Preventive Services Task Force recommends lung cancer screening (LCS) to promote early lung cancer detection, and tobacco cessation services are strongly recommended in adjunct. Screen ASSIST (NCT03611881) is a randomized factorial trial to ascertain the best tobacco treatment intervention for smokers undergoing LCS; trial outreach is conducted during 3 recruitment points (RPs): when LCS is ordered (RP1), at screening (RP2), and following results (RP3). Among 177 enrollees enrolled from April 2019 to March 2020, 31.6% enrolled at RP1, 13.0% at RP2, and 55.4% at RP3. The average number of enrollees (per 1000 recruitment days) was 2.26 in RP1, 3.37 in RP2, and 1.04 in RP3. LCS provides an opportunity to offer tobacco treatment at multiple clinical timepoints. Repeated and proactive outreach throughout the LCS experience was beneficial to enrolling patients in tobacco cessation services.
登录
查看更多内容
影响因子:
2.2
作者:
Neil JM;Chang Y;Goshe B;Rigotti N;Gonzalez I;Hawari S;Ballini L;Haas JS;Marotta C;Wint A;Harris K;Crute S;Flores E;Park ER
通讯作者:
Park ER
影响因子:
2.2
作者:
Neil JM;Marotta C;Gonzalez I;Chang Y;Levy DE;Wint A;Harris K;Hawari S;Noonan E;Styklunas G;Crute S;Howard SE;Sheppard J;Lennes IT;Jacobson F;Flores EJ;Haas JS;Park ER;Rigotti NA
通讯作者:
Rigotti NA
影响因子:
5.1
作者:
Nguyen-Grozavu, France T.;Pierce, John P.;Trinidad, Dennis R.
通讯作者:
Trinidad, Dennis R.
影响因子:
39
作者:
Zeliadt, Steven B.;Heffner, Jaimee L.;Au, David H.
通讯作者:
Au, David H.
影响因子:
3.2
作者:
Lennes, Inga T.;Luberto, Christina M.;Park, Elyse R.
通讯作者:
Park, Elyse R.